Newpath
Startup rounds since 2020 with a Newpath investor on the board, and the firm's own fund filings.
Raises
7
since 2020
Unannounced
0
no announcement found, of those filed since 2025
Funds
4
fund filings under the firm's name
Rounds
- Rinascera Therapeutics, Inc.$2.5M
- DermBiont, Inc.$32.7M
- Autobahn Therapeutics, Inc.$101M
- Chroma Medicine, Inc.$135M
- Avelo, Inc.$18.3M
- Kojin Therapeutics, Inc.$30.2M
- Houston Air Holdings, Inc.$87.7M
By year
| Year | Raises | Unannounced |
|---|---|---|
| 2025 | 1 | 0 |
| 2024 | 2 | — |
| 2023 | 2 | — |
| 2021 | 1 | — |
| 2020 | 1 | — |
Raises are checked for an announcement from 2025 on.
Funds
The firm's own fund filings, each at its latest filing.
| Fund | Filed | Size | Raised |
|---|---|---|---|
| Newpath Partners IV, L.P. | 28 May 2026 | $300M | — |
| Newpath Partners III, L.P. | 22 Apr 2024 | $350M | $273M |
| Newpath Partners II, L.P. | 7 May 2021 | $350M | $343M |
| Newpath Partners, L.P. | 22 Feb 2019 | $125M | $111M |
Listed because a Newpath fund's filing names a director of each company. A name match is not a verified identity.